is an advanced and high-tech cancer gene testing technique.
Cancer is a genome disease, also known as a genetic mutation. Understanding this principle, we have successfully developed the OncoGS test to target gene mutations in Vietnamese cancer patients.
The test is intended to check most of the therapeutic mutations widely used by Vietnamese oncologists, licensed by the Food and Drug Administration (FDA) of the United States, and recommended by prestigious cancer organizations worldwide.
This test is developed for targeted therapy, which is an approach of using medications that only target the tumorigenesis mechanism with high therapeutic efficacy and fewer side effects than conventional treatments such as radiation therapy and chemotherapy.
|Lung cancer||Osimertinib, Afatinib, Mobocertinib, Alectinib, Lorlatinib|
|Colorectal cancer||Cetuximab hoặc Panitumumab|
|Breast cancer||Olaparib, Talazoparib|
|Ovarian cancer||Niraparib, Olaparib|
(*) Điều trị đích được Cục thực phẩm và Dược phẩm Hoa Kỳ (FDA) phê duyệt
|NO||Testing for cancer-associated genetic mutations||Testing genes|
|01||Lung cancer||EGFR, KRAS, NRAS, BRAF, ALK-rearrangement, ROS1-rearrangement.|
|02||Colorectal cancer||KRAS, NRAS, BRAF, MLH1, MSH2 và MSH6|
|03||Breast cancer/Ovarian/Pancreas||BRCA1, BRCA2, PIK3CA.|
GET MEDICAL CONSULTATION FROM DOCTORS
Tư vấn di truyền